PLTU yields 39.05% · MRK yields 3.25%● Live data
📍 PLTU pulled ahead of the other in Year 1
Combined, PLTU + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PLTU + MRK for your $10,000?
The fund, under normal circumstances, invests at least 80% of its net assets (plus any borrowings for investment purposes) in the securities of PLTR and financial instruments, such as swap agreements and options, that, in combination, provide 2X daily leveraged exposure to PLTR, consistent with the fund’s investment objective. The fund is non-diversified.
Full PLTU Calculator →Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.